LAUREN RUNYON: Open Payments
NPI 1174045249 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 4 payments from 4 companies in 2025. Trend: 2023 $619 · 2024 $711 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Blueprint Medicines Corporation | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| GENZYME CORPORATION | 1 | $78 |
| Grifols USA, LLC | 1 | $21 |
Products named: AYVAKIT, FASENRA, Xembify.
Industry payments across TX — which companies pay providers there.
